![New Study: Buprenorphine for Opioid Use Disorder Underused in Washington State | Addictions, Drug & Alcohol Institute New Study: Buprenorphine for Opioid Use Disorder Underused in Washington State | Addictions, Drug & Alcohol Institute](https://adai.uw.edu/wordpress/wp-content/uploads/buprenorphine.jpg)
New Study: Buprenorphine for Opioid Use Disorder Underused in Washington State | Addictions, Drug & Alcohol Institute
![Microdosing Buprenorphine to Treat Opioid Use Disorder | Newsroom | Albert Einstein College of Medicine Microdosing Buprenorphine to Treat Opioid Use Disorder | Newsroom | Albert Einstein College of Medicine](https://www.einsteinmed.edu/images/dynamichomeimages/research-briefs/benjamin-hayes-microdosing-buprenorphine-to-treat-opioid-use-disorder.jpg)
Microdosing Buprenorphine to Treat Opioid Use Disorder | Newsroom | Albert Einstein College of Medicine
![BUPRENORPHINE AND NALOXONE (buprenorphine and naloxone) sublingual tablets CIII 8 mg/2 mg | Mallinckrodt Pharmaceuticals BUPRENORPHINE AND NALOXONE (buprenorphine and naloxone) sublingual tablets CIII 8 mg/2 mg | Mallinckrodt Pharmaceuticals](https://www.mallinckrodt.com/globalassets/images/product-images/addiction-treatment/buprenorphine-and-naloxone/buprenorphine-hcl-and-naloxone-hcl-8mg-2mg-tabs-lg.jpg)
BUPRENORPHINE AND NALOXONE (buprenorphine and naloxone) sublingual tablets CIII 8 mg/2 mg | Mallinckrodt Pharmaceuticals
![Government Eliminates Waiver Requirement for Doctors Prescribing the Addiction Treatment Medication Buprenorphine - The National Academy for State Health Policy Government Eliminates Waiver Requirement for Doctors Prescribing the Addiction Treatment Medication Buprenorphine - The National Academy for State Health Policy](https://eadn-wc03-6094147.nxedge.io/cdn/wp-content/uploads/2021/01/Buprenorphine_naloxone_Tablets_Bottle-scaled.jpg)